The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
Paraneoplastic microangiopathic haemolytic anaemia (MAHA) is a rare condition characterised by tumour-driven erythrocyte destruction and platelet consumption. It is uncommon in colorectal cancer (CRC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback